Study to Find the Highest Safe Dose of Soluble Guanylate Cyclase (sGC) Activator, BAY 1211163 Administered as Multiple Doses by Inhalation to Patients Who Cannot Breathe by Their Own and Suffer From a Type of Lung Failure That Causes Fluid to Build up in the Lungs Making Breathing Difficult (ARDS)
Clinical trial NCT04609943 · TERMINATED
Trial details
- NCT number
- NCT04609943
- Sponsor
- Bayer
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-24
- Primary completion
- 2023-08-17
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.